News: July 2020 – WHO: Eleven New Psychoactive Substances to be considered for international control by 43rd ECDD meeting

July 2020 – WHO: Eleven New Psychoactive Substances to be considered for international control by 43rd ECDD meeting

Geneva, Switzerland – July 2020: The World Health Organization (WHO) evaluates the dependence-producing properties and potential harm to health of psychoactive substances. Recommendations from the WHO regarding international control under the International Drug Control Conventions are made to the Secretary-General of the United Nations and are subject to a vote by the United Nations Commission on Narcotic Drugs (CND).

Eleven new psychoactive substances (NPS) will be considered for review at the 43rd meeting of the WHO Expert Committee on Drug Dependence (ECDD), including three benzodiazepines, three dissociatives, two synthetic cannabinoids, one hallucinogen, one stimulant and one synthetic opioid. The ECDD meeting will be held in Geneva from 12-16 October 2020. Analysis and data from UNODC’s Early Warning Advisory on NPS (EWA) has been made available to WHO for the prioritization of NPS by its Expert Committee on Drug Dependence.

Benzodiazepines

Flubromazolam

Clonazolam

Diclazepam

Hallucinogens

5-Methoxy-N,N-diallyltryptamine (5-MeO-DALT)

Dissociatives

Diphenidine

2-MeO-diphenidine

3-Methoxyphencyclidine (3-Meo-PCP)

Stimulants

3F-Phenmetrazine (3-Fluorophenmetrazine, 3-FPM)